BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7760880)

  • 1. Treatment of acute myelogenous leukemia.
    Ghaddar H; Anderlini P; Estey E
    N Engl J Med; 1995 Jun; 332(25):1717-8; author reply 1718-9. PubMed ID: 7760880
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current situation and perspective for treatment of acute myelogenous leukemia in adults].
    Fukushima T; Ueda T
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute myelogenous leukemia.
    Meisenberg B
    N Engl J Med; 1995 Jun; 332(25):1718; author reply 1718-9. PubMed ID: 7619165
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indications for allogeneic bone marrow transplantation (BMT) in adult acute myelogenous leukemia: matched-pair analysis in comparison with chemotherapy in patients achieving initial remission].
    Sakura T
    Rinsho Ketsueki; 2001 May; 42(5):380-4. PubMed ID: 11452455
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bone marrow transplantation in the treatment of acute leukemias].
    Moiseev SI; Ganapiev AA; Abdulkadyrov KM
    Ter Arkh; 1996; 68(12):8-10. PubMed ID: 9054052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why is clinical progress in acute myelogenous leukemia so slow?
    Rowe JM
    Best Pract Res Clin Haematol; 2008 Mar; 21(1):1-3. PubMed ID: 18342806
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update.
    Linker CA; Damon LE; Ries CA; Rugo HS; Wolf JL
    Semin Oncol; 1993 Aug; 20(4 Suppl 4):40-8; quiz 49. PubMed ID: 8342075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute myelogenous leukaemia.
    Löwenberg B
    J Intern Med Suppl; 1997; 740():17-22. PubMed ID: 9350177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia.
    Rizzieri DA; O'Brien JA; Broadwater G; Decastro CM; Dev P; Diehl L; Beaven A; Lagoo A; Gockerman JP; Chao NJ; Moore JO
    Cancer; 2009 Jul; 115(13):2922-9. PubMed ID: 19452542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse and death during first remission in acute myeloid leukemia.
    Yanada M; Garcia-Manero G; Borthakur G; Ravandi F; Kantarjian H; Estey E
    Haematologica; 2008 Apr; 93(4):633-4. PubMed ID: 18379012
    [No Abstract]   [Full Text] [Related]  

  • 12. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.
    Tallman MS; Pérez WS; Lazarus HM; Gale RP; Maziarz RT; Rowe JM; Marks DI; Cahn JY; Bashey A; Bishop MR; Christiansen N; Frankel SR; García JJ; Ilhan O; Laughlin MJ; Liesveld J; Linker C; Litzow MR; Luger S; McCarthy PL; Milone GA; Pavlovsky S; Phillips GL; Russell JA; Saez RA; Schiller G; Sierra J; Weiner RS; Zander AR; Zhang MJ; Keating A; Weisdorf DJ; Horowitz MM
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):204-16. PubMed ID: 16443518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome.
    Kröger N; Brand R; van Biezen A; Cahn JY; Slavin S; Blaise D; Sierra J; Zander A; Niederwieser D; de Witte T;
    Bone Marrow Transplant; 2006 Jan; 37(2):183-9. PubMed ID: 16299545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An early phase II study of autologous peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission. Japan Blood Cell Transplantation Study Group].
    Kawano F; Kiyokawa T; Shinagawa K; Takenaka K; Imajo K; Hayashi S; Hirota Y; Ohno H; Tsuda H; Gondo H; Shibuya T; Hisano S; Harada M; Ogawa M; Takaku F
    Rinsho Ketsueki; 1999 Oct; 40(10):1051-7. PubMed ID: 10565221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of patients > or =60 years with acute myelogenous leukemia.
    Lashkari A; Lowe T; Collisson E; Paquette R; Emmanouilides C; Territo M; Schiller G
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):466-71. PubMed ID: 16545730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
    Dengler R; Plewan A; Münstermann U; Busch R; Eger G; Emmerich B
    Clin Cancer Res; 1995 Feb; 1(2):199-205. PubMed ID: 9815974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.
    Ayash LJ; Ratanatharathorn V; Braun T; Silver SM; Reynolds CM; Uberti JP
    Am J Hematol; 2007 Jan; 82(1):6-14. PubMed ID: 16986128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous stem cell transplantation for acute myelogenous leukemia in first complete remission: a 6-year follow-up study of 101 patients from a single institution.
    Vey N; Bouabdallah R; Stoppa A; Faucher C; Lafage M; Chabannon C; Sainty D; Gastaut J; Maraninchi D; Blaise D
    Bone Marrow Transplant; 2004 Jan; 33(2):177-82. PubMed ID: 14647259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary study on postremission therapy courses in acute myeloid leukemia].
    Mi Y; Bian S; Xue Y
    Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):520-3. PubMed ID: 11769676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myelogenous leukemia in children. ANLL9205 study by Children's Cancer and Leukemia Study Group (CCLSG)].
    Mimaya J; Horikoshi Y; Shimizu H; Maeda H; Koizumi S; Kawakami K; Watanabe A; Utsumi J; Kikuta A; Oka T; Mugishima H; Kawamura N; Gushiken T; Ohta S; Yamamura Y; Ishida Y; Sekine I; Okada N; Fujimoto T
    Rinsho Ketsueki; 1997 Feb; 38(2):100-7. PubMed ID: 9059063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.